Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 191

    1.

    CCAAT/enhancer binding protein alpha uses distinct domains to prolong pituitary cells in the growth 1 and DNA synthesis phases of the cell cycle.

    Liu W, Enwright JF 3rd, Hyun W, Day RN, Schaufele F.

    BMC Cell Biol. 2002 Mar 21;3:6.PMID: 11914124 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A PIT-1 homeodomain mutant blocks the intranuclear recruitment of the CCAAT/enhancer binding protein alpha required for prolactin gene transcription.

    Enwright JF 3rd, Kawecki-Crook MA, Voss TC, Schaufele F, Day RN.

    Mol Endocrinol. 2003 Feb;17(2):209-22.PMID: 12554749 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.

    Wu FY, Chen H, Wang SE, ApRhys CM, Liao G, Fujimuro M, Farrell CJ, Huang J, Hayward SD, Hayward GS.

    J Virol. 2003 Jan;77(2):1481-500.PMID: 12502863 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Imaging the localized protein interactions between Pit-1 and the CCAAT/enhancer binding protein alpha in the living pituitary cell nucleus.

    Day RN, Voss TC, Enwright JF 3rd, Booker CF, Periasamy A, Schaufele F.

    Mol Endocrinol. 2003 Mar;17(3):333-45. Epub 2002 Dec 12.PMID: 12554785 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    CCAAT/enhancer binding protein alpha assembles essential cooperating factors in common subnuclear domains.

    Schaufele F, Enwright JF 3rd, Wang X, Teoh C, Srihari R, Erickson R, MacDougald OA, Day RN.

    Mol Endocrinol. 2001 Oct;15(10):1665-76.PMID: 11579200 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.

    Keeshan K, Santilli G, Corradini F, Perrotti D, Calabretta B.

    Blood. 2003 Aug 15;102(4):1267-75. Epub 2003 Apr 17.PMID: 12702500 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha.

    Wu FY, Tang QQ, Chen H, ApRhys C, Farrell C, Chen J, Fujimuro M, Lane MD, Hayward GS.

    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10683-8. Epub 2002 Jul 26.PMID: 12145325 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Dynamic interactions between Pit-1 and C/EBPalpha in the pituitary cell nucleus.

    Demarco IA, Voss TC, Booker CF, Day RN.

    Mol Cell Biol. 2006 Nov;26(21):8087-98. Epub 2006 Aug 14.PMID: 16908544 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.
    12.

    Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).

    Wu FY, Wang SE, Tang QQ, Fujimuro M, Chiou CJ, Zheng Q, Chen H, Hayward SD, Lane MD, Hayward GS.

    J Virol. 2003 Aug;77(16):8893-914.PMID: 12885907 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis.

    Wang QF, Cleaves R, Kummalue T, Nerlov C, Friedman AD.

    Oncogene. 2003 May 1;22(17):2548-57.PMID: 12730669 [PubMed - indexed for MEDLINE]Related articles

    14.

    AML1 stimulates G1 to S progression via its transactivation domain.

    Bernardin F, Friedman AD.

    Oncogene. 2002 May 9;21(20):3247-52.PMID: 12082641 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.

    Asou H, Gombart AF, Takeuchi S, Tanaka H, Tanioka M, Matsui H, Kimura A, Inaba T, Koeffler HP.

    Genes Chromosomes Cancer. 2003 Feb;36(2):167-74.PMID: 12508245 [PubMed - indexed for MEDLINE]Related articles

    18.

    CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.

    Yang L, Jiang Y, Wu SF, Zhou MY, Wu YL, Chen GQ.

    Carcinogenesis. 2008 Feb;29(2):291-8. Epub 2007 Nov 16.PMID: 18024476 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest.

    Barone MV, Crozat A, Tabaee A, Philipson L, Ron D.

    Genes Dev. 1994 Feb 15;8(4):453-64.PMID: 8125258 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.

    Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD.

    Mol Cancer Res. 2005 Oct;3(10):585-96.PMID: 16254192 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination